NeurosciencebioRxivPreprint
From APOE Genetics to AI-Designed Drug Candidates: An Integrated Pipeline for Oral, Brain-Penetrant ACAT1 Inhibitors in Alzheimer's Disease
Sharad Agarwal, Rory Popert, Paul‐Michael Agapow…·Shikta Gupta
This paper presents an AI-driven drug discovery platform for designing oral, brain-penetrant ACAT1 inhibitors for Alzheimer's disease, identifying promising lead candidates with favorable properties.
DOI 10.64898/2026.05.21.727002